| SCHIZOPHRENIA RESEARCH | 卷:226 |
| Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness | |
| Article | |
| Kelsven, Skylar1  de la Fuente-Sandoval, Camilo2,3  Achim, Cristian L.4  Reyes-Madrigal, Francisco2  Mirzakhanian, Heline4  Domingues, Isabel4  Cadenhead, Kristin4  | |
| [1] Univ Calif San Diego, Joint Doctoral Program Clin Psychol, San Diego State Univ, San Diego, CA 92103 USA | |
| [2] Inst Nacl Neurol & Neurocirugia INNN, Lab Expt Psychiat, Mexico City, DF, Mexico | |
| [3] INNN, Neuropsychiat Dept, Mexico City, DF, Mexico | |
| [4] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA | |
| 关键词: Inflammation; Immune system; Inflammatory analytes; Antipsychotic medication; Clinical high risk for psychosis; First episode psychosis; | |
| DOI : 10.1016/j.schres.2020.01.003 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Introduction: Research examining the role of inflammation in psychosis has produced inconsistent results. Variables that influence inflammation, including antipsychotic medication, are inconsistently controlled across studies and variation of inflammatory analytes across stages of psychosis may also influence findings. The purpose of this study was to assess for evidence of immuno-inflammatory dysregulation across the stages of early psychosis. We examined a immuno-inflammatory analytes in subjects at clinical high risk (CHR) for developing a psychotic disorder, antipsychotic-naive (-n) and antipsychotic treated (-a) subjects in their first episode of psychosis (FEP), and healthy control (HC) subjects. Methods: A total of 11 subjects at CHR, 50 subjects within their FEP (40 FEP-n, 10 FEP-a), and 10HC subjects were recruited from early psychosis programs in San Diego and Mexico City. Plasma was collected for biomarker assay. Results: Immuno-inflammatory analytes significantly differed between groups: Interferon-gamma (IFN-gamma), Interleukin-10 (IL-10), Eotaxin-1, Interferon Gamma-Induced Protein-10 (IP-10), Monocyte Chemotactic Protein-1 (MCP-1), Macrophage-Derived Chemokine (MDC), Macrophage Inflammatory Protein-1 beta (MIP-1 beta), Thymus and Activation Regulated Chemokine (TARC), and Brain Derived Neurotropic Factor (BDNF). Post-hoc analyses revealed an overall pattern of higher levels of IL-10, MCP-1, MIP-1 beta, TARC, and BDNF in CHR as compared to FEP-a, FEP-n, and HC subjects. Conclusions: Results reveal a profile of immuno-inflammatory dysregulation in early stages of psychosis prior to psychotic conversion and treatment with antipsychotic medication. The CHR phase of early psychosis may represent a period of increased immuno-inflammatory activation, but due to limited sample size, these results deserve replication in a well characterized early psychosis population. (C) 2020 Published by Elsevier B.V.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_schres_2020_01_003.pdf | 459KB |
PDF